Research programme: phosphodiesterase 4 inhibitors - Tetra Discovery Partners

Drug Profile

Research programme: phosphodiesterase 4 inhibitors - Tetra Discovery Partners

Alternative Names: PDE4 inhibitors - Tetra Discovery Partners; PDE4 modulators - Tetra Discovery Partners; PDE4B inhibitor; PDE4D inhibitor; Phosphodiesterase 4 modulators - Tetra Discovery Partners

Latest Information Update: 01 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Tetra Discovery Partners
  • Class Small molecules
  • Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Alzheimer's disease; Brain injuries; Schizophrenia

Highest Development Phases

  • Preclinical Cognition disorders
  • Research Brain injuries; Huntington's disease
  • No development reported Depressive disorders; Mild cognitive impairment; Schizophrenia

Most Recent Events

  • 29 Nov 2016 Tetra Discovery Partners receives a grant from National Institute of Mental Health for development in Depressive disorders
  • 16 Jul 2016 No recent reports of development identified for research development in Depressive disorders in USA
  • 16 Jul 2016 No recent reports of development identified for research development in Mild-cognitive-impairment in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top